280 assets in Pancreatic Ductal Adenocarcinoma

Adagrasib

azd0022

Azenosertib

Cabozantinib

cdh17 car-t

Darlifarnib

Fast Laco-Stim Cdh17 Car-T

Fostamatinib

gc203 til

lt-010391

Omo-103

Rmc-5127

Saruparib

Stro-004

xh001

[111in]-fpi-2107

177lu-dfc413

177lu-ff58

[177lu]lu-nns309

[225ac]-fpi-2068

64Cu-Tz-SarAr

[68Ga]Ga-NNS309

Abbv-400

Amt-151

Aquocobalamin

asp2138

asp5834

atp150

atp152

atp162

AZD0240

azd0240: autologous, engineered t cells targeting kras g12d

bi 765049

bi 765883

Camustine

Dcc-3084

dr-0202

Drug: Ibi3028

Ezabenlimab

Falimarev

Fpi-2053

Futibatinib

[Ga-68]-Pnt6555

hu5B1-TCO

Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer

Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Tigit (T-Cell Immunoreceptor With Ig Domain And Itim, V-Set Ig Member 9, Vsig9, V-Set And Transmembrane Member 3, Vstm3)], Humanized Monoclonal Antibody; Gamma1 Heavy Chain Humanized (1-448) [Vh (Homo Sapiens Ighv3-48*01 (90.8%) -(Ighd) -Ighj4*01 (92.3%)) Cdr-Imgt [8.8.12] (26-33.51-58.97-108) (1-119) -Homo Sapiens Ighg1*01, G1M17,1, G1V14 Ch2 A1.3, A1.2 (Ch1 K120 (216) (120-217), Hinge 1-15 (218-232), Ch2 L1.3>A (236), L1.2>A (237) (233-342), Ch3 D12 (358), L14 (360) (343-447), Chs K>Del (448)) (120-448)], (222-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-16*01 (89.5%) -Igkj4*01 (100%)) Cdr-Imgt [6.3.9] (27-32.50-52.89-97) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (228-228'':231-231'')-Bisdisulfide, Produced In A Chinese Hamster Ovary (Cho)-K1 Cell Line, Glycoform Alfa

Inalimarev

Itraconazole

Ivosidenib

Janx008